{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:53:27Z","timestamp":1791910407595,"version":"4.3.4"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["72361127501-2023YFVA1007"],"award-info":[{"award-number":["72361127501-2023YFVA1007"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.vaccine.2026.129185","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:04:36Z","timestamp":1790690676000},"page":"129185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Public availability and completeness of vaccine product labeling in China"],"prefix":"10.1016","volume":"93","author":[{"given":"Yingtian","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyuan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reshma","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqing","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luwen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph S.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.vaccine.2026.129185_bb0005","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.drudis.2016.06.006","article-title":"FDA drug labeling: rich resources to facilitate precision medicine, drug safety, and regulatory science","volume":"21","author":"Fang","year":"2016","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.vaccine.2026.129185_bb0010","unstructured":"Food and Drug Administration. FDA Review of Vaccine Labeling Requirements for Warnings, Use Instructions, and Precautionary Information. June 13, 2024. Accessed December 26, 2025. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/fda-review-vaccine-labeling-requirements-warnings-use-instructions-and-precautionary-information."},{"key":"10.1016\/j.vaccine.2026.129185_bb0015","unstructured":"European Medicines Agency. Product-information requirements. December 31, 2009. Accessed December 26, 2025. https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/marketing-authorisation\/product-information-requirements."},{"key":"10.1016\/j.vaccine.2026.129185_bb0020","unstructured":"World Health Organization. Guidelines for the international packaging and shipping of vaccines. Accessed December 26, 2025. https:\/\/iris.who.int\/items\/2f72b17b-cb47-42a5-8d28-42293a5ddb24."},{"key":"10.1016\/j.vaccine.2026.129185_bb0025","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ebiom.2016.08.042","article-title":"The state of vaccine confidence 2016: global insights through a 67-country survey","volume":"12","author":"Larson","year":"2016","journal-title":"EBioMedicine"},{"issue":"3 Suppl","key":"10.1016\/j.vaccine.2026.129185_bb0030","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/j.ajog.2012.06.075","article-title":"Influenza immunization during pregnancy: US regulatory perspective","volume":"207","author":"Marshall","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129185_bb0035","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00228-016-2151-9","article-title":"An evaluation of the completeness of drug-drug interaction-related information in package inserts","volume":"73","author":"Ng","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129185_bb0040","doi-asserted-by":"crossref","DOI":"10.1080\/14760584.2026.2708198","article-title":"When precision medicine meets rigid vaccination: bridging the policy gap for patients on biologics","volume":"25","author":"He","year":"2026","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2026.129185_bb0045","unstructured":"International Council for Harmonisation. ICH E2C (R2) Periodic benefit-risk evaluation report - Scientific guideline. Accessed July 5, 2026. https:\/\/www.ema.europa.eu\/en\/ich-e2c-r2-periodic-benefit-risk-evaluation-report-scientific-guideline."},{"key":"10.1016\/j.vaccine.2026.129185_bb0050","unstructured":"National Medical Products Administration. Measures for the Administration of Drug Registration. Accessed July 4, 2026. https:\/\/www.gov.cn\/gongbao\/content\/2020\/content_5512563.htm."},{"key":"10.1016\/j.vaccine.2026.129185_bb0055","unstructured":"National Medical Products Administration. Technical Guidance for Clinical Changes of Listed Chemical Drugs and Biologics. Accessed July 4, 2026. https:\/\/www.cde.org.cn\/main\/news\/viewInfoCommon\/2e4f517d9c63586ea000481618b97480."},{"key":"10.1016\/j.vaccine.2026.129185_bb0060","unstructured":"National Medical Products Administration. 2006 Regulations and guidelines for the instructions of chemical drugs and biological products. Accessed August 14, 2026. https:\/\/www.cde.org.cn\/main\/policy\/view\/cb5923d6cdaf25faa695d47d90069072."},{"key":"10.1016\/j.vaccine.2026.129185_bb0065","unstructured":"National Medical Products Administration. 2022 Regulations and guidelines for the instructions of chemical drugs and biological products. Accessed August 25, 2026. https:\/\/www.cde.org.cn\/main\/news\/viewInfoCommon\/f181ed96619e3bef4ce8154bb66d91bb."},{"key":"10.1016\/j.vaccine.2026.129185_bb0070","unstructured":"National Medical Products Administration. Guidelines for writing clinical information in vaccine instructions. Accessed August 25, 2026. https:\/\/www.cde.org.cn\/main\/news\/viewInfoCommon\/eb9d0876f81aea8e16ed3215cafdf70e."},{"key":"10.1016\/j.vaccine.2026.129185_bb0075","unstructured":"National Medical Products Administration. Vaccine administration law of the People's Republic of China. Accessed August 12, 2026. https:\/\/english.nmpa.gov.cn\/2019-07\/29\/c_773013.htm."},{"key":"10.1016\/j.vaccine.2026.129185_bb0080","unstructured":"National Medical Products Administration. Data inquiry. Accessed December 26, 2025. https:\/\/www.nmpa.gov.cn\/datasearch\/home-index.html?itemId=ff80808183cad7500184088665711800#category=yp."},{"key":"10.1016\/j.vaccine.2026.129185_bb0085","unstructured":"Vaccine package insert and label database. Accessed December 26, 2025. https:\/\/www.nmpa.gov.cn\/datasearch\/search-result.html."},{"key":"10.1016\/j.vaccine.2026.129185_bb0090","unstructured":"National Institute for Food and Drug Control. Summary of the public announcement of biological product batch release products. Accessed December 26, 2025. https:\/\/bio.nifdc.org.cn\/pqf\/search.do?formAction=pqfGs."},{"key":"10.1016\/j.vaccine.2026.129185_bb0095","unstructured":"European public assessment reports: background and context | European Medicines Agency (EMA). September 27, 2018. Accessed December 26, 2025. https:\/\/www.ema.europa.eu\/en\/medicines\/what-we-publish-medicines-when\/european-public-assessment-reports-background-context."},{"key":"10.1016\/j.vaccine.2026.129185_bb0100","unstructured":"Research C for BE and. Vaccines licensed for use in the United States. FDA. Published online December 16, 2025. Accessed December 26, 2025. https:\/\/www.fda.gov\/vaccines-blood-biologics\/vaccines\/vaccines-licensed-use-united-states."},{"key":"10.1016\/j.vaccine.2026.129185_bb0105","doi-asserted-by":"crossref","unstructured":"Matsui R, Yamaguchi K, Ting I, et al. Survey result for E-labeling initiatives in Asia. Accessed June 27, 2026. doi: https:\/\/doi.org\/10.1007\/s43441-022-00462-5.","DOI":"10.1007\/s43441-022-00462-5"},{"key":"10.1016\/j.vaccine.2026.129185_bb0110","unstructured":"hsa-vel-guidelines.pdf. Accessed June 28, 2026. https:\/\/file.go.gov.sg\/hsa-vel-guidelines.pdf."},{"issue":"10","key":"10.1016\/j.vaccine.2026.129185_bib121","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1007\/s11606-021-06943-x","article-title":"Characteristics of Preapproval and Postapproval Studies of Vaccines Granted Accelerated Approval by the US Food and Drug Administration","volume":"36","author":"Egilman","year":"2021","journal-title":"J Gen Intern Med."},{"issue":"18","key":"10.1016\/j.vaccine.2026.129185_bb0115","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1056\/NEJMp0907708","article-title":"Lost in transmission \u2014 FDA drug information that never reaches clinicians","volume":"361","author":"Schwartz","year":"2009","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.vaccine.2026.129185_bb0120","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1007\/s11606-012-2222-2","article-title":"Getting to better prescription drug information","volume":"27","author":"Woloshin","year":"2012","journal-title":"J Gen Intern Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:24:43Z","timestamp":1791908683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26009941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":25,"alternative-id":["S0264410X26009941"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129185","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Public availability and completeness of vaccine product labeling in China","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129185","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"129185"}}